Health economic analysis of third-line interventions in diffuse large B-cell lymphomas in Germany: applying the efficiency frontier

BACKGROUND: In the past decades, highly innovative treatments in the field of diffuse large B-cell lymphoma (DLBCL) became available in clinical practice. The aim of this study was to assess the cost–benefit relation of third-line interventions in DLBCL from a German payer perspective. METHODS: Clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Jakobs, Florian, Jeck, Julia, Ahmadi, Paymon, Kron, Anna, Kron, Florian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743754/
https://www.ncbi.nlm.nih.gov/pubmed/36503527
http://dx.doi.org/10.1186/s12962-022-00400-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743754/
https://www.ncbi.nlm.nih.gov/pubmed/36503527
http://dx.doi.org/10.1186/s12962-022-00400-0

Ejemplares similares